Main
>
ONCOLOGY (**)
>
Kidney Cancer>RCC>MET ***
>
Treatment
>
USA. M. PembrolizuMAb+Axitinib
>
(*) JP Approval Date: 2019. 12.20
(*) JP Approval Date: 2019. 12.20's products
This section has no products